Christopher Anzalone

Insider Reports History

Location
Pasadena, CA
Signature
/s/Christopher Anzalone
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Anzalone:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARROWHEAD PHARMACEUTICALS, INC. Chief Executive Officer, Director Common Stock 3,792,739 $251,799,942 $66.39 02 Jan 2026 Direct
ARROWHEAD PHARMACEUTICALS, INC. Chief Executive Officer, Director Stock Option (right to buy Common Stock) 0 29 Dec 2025 Direct

Insider Reports Filed by Christopher Anzalone

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARWR ARROWHEAD PHARMACEUTICALS, INC. 02 Jan 2026 2 -$871,703 4 Chief Executive Officer, Director 05 Jan 2026, 21:39
ARWR ARROWHEAD PHARMACEUTICALS, INC. 29 Dec 2025 6 -$3,257,460 4 Chief Executive Officer, Director 30 Dec 2025, 17:46
ARWR ARROWHEAD PHARMACEUTICALS, INC. 19 Dec 2025 5 -$1,771,022 4 Chief Executive Officer, Director 23 Dec 2025, 18:01
ARWR ARROWHEAD PHARMACEUTICALS, INC. 17 Dec 2025 4 -$5,443,462 4 Chief Executive Officer, Director 19 Dec 2025, 18:56
ARWR ARROWHEAD PHARMACEUTICALS, INC. 12 Dec 2025 13 -$12,348,802 4 Chief Executive Officer, Director 16 Dec 2025, 13:14
ARWR ARROWHEAD PHARMACEUTICALS, INC. 09 Apr 2025 5 -$1,533,337 4 Chief Executive Officer, Director 11 Apr 2025, 18:20
ARWR ARROWHEAD PHARMACEUTICALS, INC. 13 Mar 2025 2 -$774,975 4 Chief Executive Officer, Director 17 Mar 2025, 17:45
ARWR ARROWHEAD PHARMACEUTICALS, INC. 03 Mar 2025 6 -$2,949,334 4 Chief Executive Officer, Director 05 Mar 2025, 18:32
ARWR ARROWHEAD PHARMACEUTICALS, INC. 07 Feb 2025 1 +$191,955 4 Chief Executive Officer, Director 10 Feb 2025, 18:23
ARWR ARROWHEAD PHARMACEUTICALS, INC. 02 Jan 2025 1 -$219,456 4 Chief Executive Officer, Director 06 Jan 2025, 18:07
ARWR ARROWHEAD PHARMACEUTICALS, INC. 23 Dec 2024 1 -$246,109 4 Chief Executive Officer, Director 23 Dec 2024, 16:39
ARWR ARROWHEAD PHARMACEUTICALS, INC. 18 Dec 2024 4 -$567,486 4 Chief Executive Officer, Director 20 Dec 2024, 18:04
ARWR ARROWHEAD PHARMACEUTICALS, INC. 31 Jan 2024 4 -$1,023,984 4 Chief Executive Officer, Director 02 Feb 2024, 17:25
ARWR ARROWHEAD PHARMACEUTICALS, INC. 02 Jan 2024 2 -$308,637 4 Chief Executive Officer, Director 04 Jan 2024, 17:25
ARWR ARROWHEAD PHARMACEUTICALS, INC. 20 Dec 2023 1 -$342,480 4 Chief Executive Officer, Director 22 Dec 2023, 17:04
ARWR ARROWHEAD PHARMACEUTICALS, INC. 25 Oct 2023 1 -$589,223 4 Chief Executive Officer, Director 27 Oct 2023, 18:23
ARWR ARROWHEAD PHARMACEUTICALS, INC. 18 Sep 2023 4 -$1,349,886 4 Chief Executive Officer, Director 20 Sep 2023, 18:10
ARWR ARROWHEAD PHARMACEUTICALS, INC. 03 May 2023 7 -$3,914,768 4 Chief Executive Officer, Director 05 May 2023, 19:04
ARWR ARROWHEAD PHARMACEUTICALS, INC. 16 Dec 2022 2 $0 4 Chief Executive Officer, Director 20 Dec 2022, 18:09
ARWR ARROWHEAD PHARMACEUTICALS, INC. 27 Sep 2022 2 -$1,250,679 4 Chief Executive Officer, Director 29 Sep 2022, 17:15
ARWR ARROWHEAD PHARMACEUTICALS, INC. 08 Jul 2022 1 $0 4 Chief Executive Officer, Director 12 Jul 2022, 19:39
ARWR ARROWHEAD PHARMACEUTICALS, INC. 07 Jul 2022 2 +$36,365 4 Chief Executive Officer, Director 11 Jul 2022, 20:08
ARWR ARROWHEAD PHARMACEUTICALS, INC. 11 Feb 2022 6 -$6,839,111 4 Chief Executive Officer, Director 14 Feb 2022, 07:54
ARWR ARROWHEAD PHARMACEUTICALS, INC. 07 Jan 2022 2 +$61,273 4 Chief Executive Officer, Director 07 Jan 2022, 20:39
ARWR ARROWHEAD PHARMACEUTICALS, INC. 01 Jan 2022 1 $0 4 Chief Executive Officer, Director 04 Jan 2022, 20:22
ARWR ARROWHEAD PHARMACEUTICALS, INC. 23 Dec 2021 2 +$61,273 4 Chief Executive Officer, Director 23 Dec 2021, 20:52
ARWR ARROWHEAD PHARMACEUTICALS, INC. 15 Dec 2021 5 -$4,053,431 4 Chief Executive Officer, Director 17 Dec 2021, 19:14
ARWR ARROWHEAD PHARMACEUTICALS, INC. 20 Oct 2021 3 -$4,274,982 4 Chief Executive Officer, Director 22 Oct 2021, 17:58